Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03038854
Other study ID # 14.16.INF
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 8, 2017
Est. completion date October 31, 2022

Study information

Verified date November 2022
Source Nestlé
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine the nutritional and cognitive effects of consuming Growing Up Milks (GUMs) and cow's milk.


Description:

Single-site, double blind, partially randomized, controlled, 4-arm parallel group clinical trial. The purpose of this study is to determine if consuming nutrient enriched growing up milk improves the nutrition status and cognitive performance in healthy toddlers.


Recruitment information / eligibility

Status Completed
Enrollment 310
Est. completion date October 31, 2022
Est. primary completion date July 11, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 17 Months to 18 Months
Eligibility Inclusion Criteria: 1. Having obtained his/her parent's(s') or his/her legal guardian written informed consent and signed and dated informed consent. 2. Age 17 - 18 months at enrolment. 3. Singleton, full-term gestational birth (= 37 completed weeks of gestation), with a birth weight of = 2.5 kg and = 4.5 kg 4. Toddler's parent(s)/guardian is of legal age of consent, has sufficient command of English language to complete the informed consent and other study documents, and is willing and able to fulfill the requirements of the study protocol 5. Toddler's parent(s)/guardian can be contacted directly by telephone or email throughout the study Exclusion Criteria: Toddlers who exhibit one or more of the following criteria are excluded from enrollment in the study: 1. Chronic infectious, metabolic, genetic illness or other disease including any condition that impacts feeding or may impact outcome measures 2. Known or suspected cows' milk protein intolerance / allergy or severe food allergies that impact diet 3. Toddlers fed vegan, vegetarian, or vegetarian plus fish diets 4. Cognitive or developmental disorders 5. Breast milk used exclusively in place of all other milk, and/or milk alternatives at 17-18 months (GUM & cows' milk group exclusion only, eligible for population group) 6. Consuming supplement(s) of relevance to the study outcome relating diet to status, docosahexaenoic acid (DHA), lutein, and/or choline in amounts >%10 requirements 7. Toddlers or toddlers' family who in the Investigator's judgment cannot be expected to comply with the protocol or study procedures

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Test GUM
Growing up milks (GUMs) are milk-based drinks with vitamins and minerals for toddlers and pre-school children.
Standard GUM
Growing up milks (GUMs) are milk-based drinks with vitamins and minerals for toddlers and pre-school children.
Cows' milk
Homogenized store-bought full fat cow's milk.

Locations

Country Name City State
Canada University of British Columbia, Children and Women's Health Centre of British Columbia Branch Vancouver

Sponsors (2)

Lead Sponsor Collaborator
Nestlé University of British Columbia

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Comparison of blood nutrient markers after 6 months of intervention To compare blood status of the key nutrients of interest after 180 days of intervention in toddlers randomized in a double-blind manner to Test GUM compared to standard GUM. A non-randomized group for comparison will drink either cows' milk (comparator group) as currently recommended by Health Canada, or participate in a reference group with no drinking or feeding interventions. 6 months
Secondary Executive function and language development To assess the effect of milk/drink on measures of neurological development. Standard and validated tools will be used in the assessment including Bayley Scales of Infant Development III 6 months
Secondary Visual acuity with Teller Acuity Cards To characterize the effects of milk/drink on visual acuity 6 months
Secondary Behavioural development To characterize the effects of milk/drink on behavioural development using standard questionnaires including the Child Behaviour Checklist (CBCL) 6 months
Secondary Dietary nutrient intake To characterize effects of milk/drink on dietary intake of energy, macronutrients and key nutrients of interest using the Food Frequency Questionnaire 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT06052553 - A Study of TopSpin360 Training Device N/A
Completed NCT05511077 - Biomarkers of Oat Product Intake: The BiOAT Marker Study N/A
Recruiting NCT04632485 - Early Detection of Vascular Dysfunction Using Biomarkers From Lagrangian Carotid Strain Imaging
Completed NCT05931237 - Cranberry Flavan-3-ols Consumption and Gut Microbiota in Healthy Adults N/A
Terminated NCT04556032 - Effects of Ergothioneine on Cognition, Mood, and Sleep in Healthy Adult Men and Women N/A
Completed NCT04527718 - Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers Phase 1
Completed NCT04107441 - AX-8 Drug Safety, Tolerability and Plasma Levels in Healthy Subjects Phase 1
Completed NCT04065295 - A Study to Test How Well Healthy Men Tolerate Different Doses of BI 1356225 Phase 1
Completed NCT04998695 - Health Effects of Consuming Olive Pomace Oil N/A
Completed NCT01442831 - Evaluate the Absorption, Metabolism, And Excretion Of Orally Administered [14C] TR 701 In Healthy Adult Male Subjects Phase 1
Terminated NCT05934942 - A Study in Healthy Women to Test Whether BI 1358894 Influences the Amount of a Contraceptive in the Blood Phase 1
Recruiting NCT05525845 - Studying the Hedonic and Homeostatic Regulation of Food Intake Using Functional MRI N/A
Completed NCT05515328 - A Study in Healthy Men to Test How BI 685509 is Processed in the Body Phase 1
Completed NCT05030857 - Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Phase 1
Completed NCT04967157 - Cognitive Effects of Citicoline on Attention in Healthy Men and Women N/A
Recruiting NCT04714294 - Evaluate the Safety, Tolerability and Pharmacokinetics Characteristics of HPP737 in Healthy Volunteers Phase 1
Recruiting NCT04494269 - A Study to Evaluate Pharmacokinetics and Safety of Tegoprazan in Subjects With Hepatic Impairment and Healthy Controls Phase 1
Completed NCT04539756 - Writing Activities and Emotions N/A
Recruiting NCT04098510 - Concentration of MitoQ in Human Skeletal Muscle N/A
Completed NCT03308110 - Bioavailability and Food Effect Study of Two Formulations of PF-06650833 Phase 1